Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$12.42 - $17.29 $1.06 Million - $1.47 Million
85,200 Added 336.76%
110,500 $1.73 Million
Q4 2023

Feb 12, 2024

BUY
$11.13 - $15.78 $281,589 - $399,234
25,300 New
25,300 $377,000
Q2 2023

Aug 11, 2023

SELL
$40.29 - $82.51 $415,067 - $850,018
-10,302 Reduced 49.58%
10,477 $434,000
Q1 2023

May 11, 2023

BUY
$56.44 - $118.81 $196,862 - $414,409
3,488 Added 20.17%
20,779 $1.25 Million
Q4 2022

Feb 13, 2023

SELL
$63.98 - $85.37 $193,411 - $258,073
-3,023 Reduced 14.88%
17,291 $1.27 Million
Q3 2022

Nov 08, 2022

SELL
$67.99 - $89.57 $2.95 Million - $3.89 Million
-43,415 Reduced 68.12%
20,314 $1.54 Million
Q2 2022

Aug 12, 2022

SELL
$56.6 - $89.9 $504,419 - $801,188
-8,912 Reduced 12.27%
63,729 $4.43 Million
Q1 2022

May 13, 2022

SELL
$60.15 - $84.52 $4.59 Million - $6.45 Million
-76,339 Reduced 51.24%
72,641 $6.02 Million
Q4 2021

Feb 11, 2022

BUY
$75.08 - $121.99 $3.13 Million - $5.09 Million
41,707 Added 38.88%
148,980 $11.2 Million
Q3 2021

Nov 10, 2021

SELL
$116.17 - $194.55 $9.8 Million - $16.4 Million
-84,359 Reduced 44.02%
107,273 $12.5 Million
Q2 2021

Aug 16, 2021

BUY
$130.4 - $225.58 $11 Million - $19.1 Million
84,466 Added 78.82%
191,632 $42.5 Million
Q1 2021

May 13, 2021

BUY
$124.11 - $190.17 $2.23 Million - $3.41 Million
17,931 Added 20.09%
107,166 $14.2 Million
Q4 2020

Feb 16, 2021

SELL
$112.16 - $174.14 $12.6 Million - $19.6 Million
-112,577 Reduced 55.78%
89,235 $15.4 Million
Q3 2020

Nov 13, 2020

SELL
$58.05 - $111.31 $2.77 Million - $5.32 Million
-47,780 Reduced 19.14%
201,812 $22.5 Million
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $5.91 Million - $7.68 Million
103,263 Added 70.57%
249,592 $14.8 Million
Q1 2020

May 14, 2020

SELL
$57.05 - $95.75 $9,641 - $16,181
-169 Reduced 0.12%
146,329 $9.85 Million
Q4 2019

Feb 13, 2020

SELL
$68.3 - $93.8 $2.49 Million - $3.42 Million
-36,489 Reduced 19.94%
146,498 $12.3 Million
Q3 2019

Nov 13, 2019

SELL
$61.86 - $97.8 $3.26 Million - $5.15 Million
-52,685 Reduced 22.36%
182,987 $13.6 Million
Q2 2019

Aug 08, 2019

SELL
$42.22 - $63.23 $4.79 Million - $7.17 Million
-113,395 Reduced 32.49%
235,672 $14.9 Million
Q1 2019

May 13, 2019

SELL
$31.96 - $56.12 $3 Million - $5.27 Million
-93,820 Reduced 21.18%
349,067 $16.8 Million
Q4 2018

Feb 14, 2019

SELL
$28.72 - $52.63 $3.95 Million - $7.23 Million
-137,450 Reduced 23.68%
442,887 $14.8 Million
Q3 2018

Nov 13, 2018

SELL
$32.0 - $52.4 $3.79 Million - $6.2 Million
-118,386 Reduced 16.94%
580,337 $30.4 Million
Q2 2018

Aug 13, 2018

SELL
$19.85 - $32.0 $4.55 Million - $7.34 Million
-229,302 Reduced 24.71%
698,723 $21.9 Million
Q1 2018

May 14, 2018

BUY
$19.3 - $23.65 $7.63 Million - $9.35 Million
395,316 Added 74.21%
928,025 $20.2 Million
Q4 2017

Feb 13, 2018

BUY
$16.3 - $21.9 $8.68 Million - $11.7 Million
532,709
532,709 $10.8 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.88B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.